United States Spine Pain Industry Outlook from 2023 to 2033

The demand for spinal pain treatment options in the United States is expected to rise at a CAGR of 10.6% during the forecast period. Total revenue in the country is projected to increase from USD 3,962.7 million in 2023 to USD 10,962.7 million by 2033. In 2022, overall sales totaled around USD 3,635.2 million in the United States.

Key Highlights

United States Revenue to Expand 2.8X by 2033

Revenue in the United States is projected to expand around 2.8X through 2033, amid a 3.2% increase in expected CAGR compared to the historical one. This is attributable to the growing prevalence of back pain and rising patient spending on spine pain management.

Spinal Non-fusion Category to Hold 36.8% Value Share in 2033

As per the latest United States spine pain industry analysis and trends, the spinal non-fusion segment is expected to hold a dominant value share of around 36.8% in 2033. This is attributable to the rising popularity of spinal non-fusion surgery. This type of surgery is gaining momentum due to its benefits, including less pain, fast recovery time, reduced risk of complications, and preservation of spinal motion.

Attributes Key Insights
United States Spine Pain Business Revenue in 2022 USD 3,635.2 million
Estimated Value in 2023 USD 3,962.7 million
Projected Value in 2033 USD 10,962.7 million
Value-based CAGR (2023 to 2033) 10.6%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Overview of Spine Pain Business in the United States

The spine pain business encompasses the analysis of multiple spinal pains and their respective therapeutic approaches aimed at addressing unmet needs and improving the quality of life for individuals. It is expected to flourish during the forecast period due to several factors, including the rising prevalence of back pain.

The growing prevalence of back pain in the United States is a prominent factor expected to drive demand during the forecast period. This is because patients suffering from back pain often opt for different treatments.

In recent years, there has been a spike in cases of back pain across the United States due to factors such as sedentary lifestyles, weight gain, and poor posture. As per the National Center for Health Statistics, around 39.0% of adults suffered from back pain in 2019. This dramatic rise in back pain is expected to boost sales growth in the United States.

Other Growth Drivers for the Spine Pain Business in the United States

  • Increasing geriatric population
  • Growing popularity of minimally invasive surgeries
  • Development of novel spine pain products and treatments
  • Rising awareness about the causes and management of back pain
  • Increasing healthcare expenditure, especially on musculoskeletal disorders and pain management
  • Rising government initiatives to promote back pain management
  • Shifting preference from non-opioid pain management to alternative back pain treatments
  • Increasing public awareness campaigns aimed at educating people about the importance of spine health
  • Availability of different treatment options for spine pain
  • Development of advanced imaging techniques in spine pain diagnosis
  • Growing demand for chronic spine pain management and non-surgical spine treatments
  • Incorporation of robotics and advanced navigation technology (computer-assisted, image-guidance) in spinal surgical procedures
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Historical United States Spine Pain Industry Analysis Vs. 2023 to 2033 Forecast

Spine pain product sales in the United States increased at a CAGR of 7.4% between 2018 and 2022. Over the assessment period, the United States is poised to exhibit a CAGR of 10.6%.

Historical CAGR (2018 to 2022) 7.4%
Forecast CAGR (2023 to 2033) 10.6%

The demand for patient-centric care is of utmost importance and a transformative trend in the spine pain business. It is mainly driven by a shift in patient expectations and recognition of the importance of tailoring care to individual needs. This trend reflects the growing desire of patients to play an active role in their healthcare decisions and to receive treatments that align with their unique circumstances, preferences, and lifestyles.

Patients are increasingly looking for treatments that recognize their unique pain experiences, taking into account elements, including pain intensity, impact on everyday life, and individual pain thresholds. This demand encourages healthcare providers to have meaningful dialogues with patients, listen carefully to their concerns, and collaborate to build treatment programs that represent their individual pain profiles.

The increasing need for patient-centered care in the spine pain business represents a fundamental shift in the healthcare landscape. This is expected to boost revenue in the United States through 2033.

Insights into Lucrative Opportunities Propelling Demand

Mobile apps designed for spine pain management can serve as versatile tools that empower patients to participate actively in their treatment journey. These apps can provide personalized exercise regimens, pain-tracking functionalities, and educational resources, allowing patients to better understand their condition and adhere to recommended therapies.

By engaging patients in their care, these apps foster a sense of ownership and accountability. They potentially lead to more effective pain management and a reduced reliance on acute interventions.

Multidisciplinary back pain apps such as the Kaia app for use on mobile devices have shown greater effectiveness than physiotherapy in combination with online education in treating patients with lower back pain. These results support those of another large study of more than 10,000 adults that showed a digital care program available through a mobile app resulted in a significant positive relationship between engagement and pain reduction.

Interdisciplinary collaboration represents a transformative opportunity in the spine pain business and a shift toward comprehensive & patient-centered care. In a landscape where spine pain often extends beyond physical discomfort to encompass psychological and emotional burdens, collaborative care models bring together experts from diverse fields.

Collaborative care models can also bring together surgeons, pain management specialists, physiotherapists, and psychologists to offer holistic treatment approaches that address the multifaceted nature of spine pain. This is set to bode well for the target business in the United States.

The interdisciplinary collaboration lies in the recognition that spine pain isn't solely a mechanical issue. It encompasses physiological, psychological, and even social dimensions.

Orthopedic spine surgeons in the United States contribute their expertise in diagnosing structural issues and performing necessary surgical interventions. Pain management specialists would play a crucial role in providing effective pain relief strategies, ensuring that patients experience comfort while undergoing treatment.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Challenges for the Target Business

Patients who lack comprehensive health insurance coverage or have high deductibles can find themselves unable to afford the necessary interventions for their spine pain. This finanacial strain can compel patients to delay or altogether forgo treatments, leading to exacerbated pain, reduced quality of life, and an increased potential for long-term complications.

Consequently, the pool of potential patients who can benefit from these treatments shrinks, adversely affecting the industry’s expansion.

  • According to the National Library of Medicine, around twice as many spine surgeries are performed in the United States as in most developed countries. The latest official comparisons show that the rate in the United States is about twice that in New Zealand, Australia, Canada, Norway, and Finland.
  • According to the Global Spine Journal, the expense associated with adult spinal deformity surgery is estimated to be as high as USD 103,143 per surgical procedure, which is a significant cost for people seeking treatment.

The economic burden extends beyond individuals to healthcare systems and insurers. The high costs of spine pain treatments strain healthcare budgets and contribute to rising healthcare expenditures. This financial stress can result in tougher decisions on reimbursement policies and coverage limitations, further restricting patients' options for receiving timely and appropriate care.

State-wise Insights

Growth Outlook by Key State

States Value-based CAGR
South Carolina 9.9%
Florida 11.3%
Virginia 10.7%
North Carolina 10.4%
California 11.7%

Rising Prevalence of Spine-related Issues Boosting Sales in South Carolina

Sales in South Carolina are expected to rise at 9.9% CAGR during the forecast period. This is attributable to the rising prevalence of spine-related issues and the presence of well-established healthcare infrastructure.

The high prevalence of obesity in South Carolina is closely related to the increasing incidence of spine-related issues. As there are several healthcare facilities in South Carolina, such as hospitals, clinics, and specialist centers, these institutions offer spine pain management services. These are estimated to improve access to care and contribute to sales growth.

The state boasts orthopedic and neurosurgical experts who specialize in spine pain treatment and surgery. This expertise is expected to attract patients seeking advanced care, particularly for complex spine conditions.

Presence of Specialized Spine Pain Treatment Centers Drive Growth in Florida

Demand in Florida is projected to increase at a CAGR of 11.3% during the assessment period. This can be attributed to the presence of several specialized spine pain treatment centers in the state and growing cases of spine diseases.

Florida hosts several specialized spine pain treatment centers, drawing patients from all over the United States. These centers offer a wide range of services, including surgical and non-surgical interventions.

Florida's focus on pain management services has led to the establishment of specialized pain clinics offering interventional and medication-based pain relief solutions. The growing inclination of patients to opt for treatments in these clinics will likely boost revenue in Florida.

Category-wise Insights

The below section highlights the prediction for the spinal non fusion segment, which is expected to hold a dominant share based on product type. It is expected to exhibit a CAGR of 10.5% through 2033.

Based on pain type, the thoracolumbar pain segment is anticipated to lead the United States. It will likely progress at 8.9% CAGR during the assessment period.

In terms of end users, the hospital segment is set to generate significant revenue in the United States. It is poised to thrive at a CAGR of 7.1% between 2023 and 2023.

Spinal Non-fusion Devices to Remain Highly Sought-after Products

Growth Outlook by Key Product Type

Product Value-based CAGR
Spinal Fusion 7.5%
Spinal Non Fusion 10.5%
Vertebral Body Replacement Systems 10.6%
Spinal Cord Stimulation 15.5%
Transcutaneous Electrical Neuromuscular Stimulation (TENS) 13.0%
Spinal Epidural Injection 13.1%

As per the latest United States spine pain industry analysis, the spinal non-fusion segment is projected to thrive at a CAGR of 10.5% during the forecast period. By 2033, the target segment is set to reach USD 4,033.3 million.

The rising usage of spinal non-fusion devices to treat spinal disorders without permanently connecting or fusing vertebrae together is expected to boost the segment. These medical implants or devices are set to be used to treat disorders, such as spinal instability, discomfort, and disc problems while permitting natural movement of the spine.

A handful of examples of spine non-fusion devices include facet arthroplasty devices, annulus repair devices, artificial disc replacement systems, nuclear disc prostheses, interspinous process decompression (IPD) devices, and pedicle screw-based dynamic stabilization systems.

Thoracolumbar Pain Type to Lead the United States

Growth Outlook by Pain Type

Pain Type Value-based CAGR
Cervical Pain 12.2%
Thoracolumbar Pain 8.9%
Lumbar Pain 11.0%
Sciatic Pain 10.7%

Based on pain type, the thoracolumbar pain segment is expected to progress at a CAGR of 8.9% during the assessment period. It will likely total a valuation of USD 1,554.8 million in 2023.

Patients in the United States often grapple with thoracolumbar pain, which resides in the mid-back where the thoracic and lumbar spine meet. This discomfort arises from irritation of the thoracolumbar facet joints. When it comes to managing or resolving this pain, they have a range of treatment options to consider.

Management of thoracolumbar pain frequently involves physical therapy and rehabilitation. The demand for these services has led to an expansion of physical therapy clinics and rehabilitation facilities, which contributes to the sales growth in the United States.

The treatment often includes pain medications, nerve blocks, and other interventional therapies. These pharmaceutical and medical interventions are expected to drive growth in the pharmaceutical and medical device sectors, thereby boosting revenue in the United States.

Hospital to Remain Leading End Users Through 2033

Growth Outlook by Key End User

Application Value-based CAGR
Hospitals 7.1%
Specialty Clinic 11.5%
Ambulatory Surgical Centers 14.6%

The hospital segment is anticipated to expand at 7.1% CAGR over the forecast period. It is predicted to total a valuation of USD 1,925.2 million by 2033.

Hospitals are typically located in convenient and accessible locations, making it easier for patients to seek care for spine pain without the need for a hospital visit. This accessibility encourages more people to access treatment, ultimately expanding the patient base in hospitals.

The ambulatory care center segment is expected to witness a higher CAGR of 14.6% through 2033. Ambulatory care centers often offer shorter wait times compared to traditional hospitals. Patients with spine pain can receive timely evaluations, diagnostic tests, and treatment, leading to faster relief and improved patient satisfaction.

Competitive Landscape

Key players are focusing on introducing novel solutions for back pain. Strategic partnerships are a priority for leading United States-based spine pain solution providers. Several players are also investing in research and development as well as implementing strategies, including acquisitions, mergers, and collaborations, to solidify their positions.

Recent Developments in Spine Pain Therapy Business

  • In May 2023, Globus Medical announced the FDA approval for its Reflect non-fusion scoliosis repair solution for young patients.
  • In July 2022, a 3-year agreement to establish the HSS/ZB Innovation Center for AI in Robotic Joint Replacement was announced by the Hospital for Special Surgery (HSS) and Zimmer Biomet Holdings, Inc. It is a leader in medical technology.

Scope of the United States Spine Pain Business Report

Attribute Details
Estimated Size (2023) USD 3,962.7 million
Projected Value (2033) USD 10,962.7 million
Anticipated Growth Rate (2023 to 2033) 10.6%
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Industry Analysis Value (USD million)
Key Regions Covered Northeast; Midwest; Southeast; Southwest; West
Key States Covered New York, New Jersey, Massachusetts, Rest of North East, Minnesota, Wisconsin, Rest of Midwest, North Carolina, South Carolina, Florida, Virginia, Rest of Southeast, Louisiana, Oklahoma, Texas, Rest of Southeast, Washington, California, New Mexico, Rest of West
Key Segments Covered Product Type, Pain Type, End User, and Region
Key Companies Profiled Zimmer, Inc. (ZimVie Inc.); Medtronic; Johnson & Johnson; Stryker Corporation; Abbott Laboratories; Boston Scientific Corporation; B Braun (Aesculap, Inc.); Becton, Dickinson and Company; Globus Medical; Alphatec Spine, Inc.; Nevro Corp; NuVasive, Inc.; Orthofix US LLC.; Surgalign Spine Technologies, Inc.; Precision Spine, Inc.
Report Coverage Sales Forecast, Competition Intelligence, Key Dynamics and Challenges, Strategic Growth Initiatives

United States Spine Pain Business Outlook by Category

By Product Type:

  • Spinal Fusion
    • Interbody Devices
    • Pedicle Screw System
    • Spinal Plating System
  • Spinal Non-Fusion
    • Annulus Repair Devices
    • Artificial Disc Replacement Systems
    • Interspinous Process Decompression (IPD) Devices
    • Pedicle Screw-based Dynamic Stabilization Systems
  • Vertebral Body Replacement Systems
  • Spinal Cord Stimulation
  • Transcutaneous Electrical Neuromuscular Stimulation (TENS)
  • Spinal Epidural Injection

By Pain Type:

  • Cervical Pain
    • Arm Pain
  • Thoracolumbar Pain
    • Arm Pain
    • Leg Pain
  • Lumbar Pain
    • Leg Pain
  • Sciatic Pain
    • Leg Pain

By End User:

  • Hospitals
  • Specialty Clinic
  • Ambulatory Surgical Centers

By Region:

  • Northeast
  • Midwest
  • Southeast
  • Southwest
  • West

Frequently Asked Questions

How big is the spine pain business in the United States?

Revenue in the United States is set to reach USD 3,962.7 million by 2023.

What is the sales forecast in the United States through 2033?

Sales in the United States are expected to total USD 10,962.7 million by 2033.

What is the demand outlook for the spine pain business in the United States?

Demand in the United States is set to rise at 10.6% CAGR through 2033.

Which product segment holds a dominant value share?

The spinal non-fusion segment held around 37.2% share in 2022.

What was the last seven years’ CAGR?

Sales in the United States increased at 7.4% CAGR from 2018 to 2022.

What is the Southeast spine pain business outlook?

The Southeast region accounted for 36.6% value share in 2022.

What percentage of people in the United States suffer from back pain?

About 29.9% of people aged 18 and older suffered from lower back pain in 2018.

How much money is spent on back pain in the United States?

Around USD 50 billion is spent by people in the United States on back pain each year.

Table of Content
	1. Executive Summary
	2. Overview
	3. Key Trends
	4. Value Added Insights
	5. Background
	6. Volume (Units) Analysis 2018 to 2022 and Forecast, 2023 to 2033
	7. Demand Pricing Analysis
	8. Demand (in Value or Size in USD million) Analysis 2018 to 2022 and Forecast, 2023 to 2033
	9. Demand Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
		9.1. Spinal Fusion
			9.1.1. Interbody Devices
			9.1.2. Pedicle Screw Systems
			9.1.3. Spinal Plating Systems
		9.2. Spinal Non-fusion
			9.2.1. Annulus Repair Devices
			9.2.2. Artificial Disc Replacement Systems
			9.2.3. Interspinous Process Decompression (IPD) Devices
			9.2.4. Pedicle Screw-based Dynamic Stabilization Systems
		9.3. Vertebral Body Replacement Systems
		9.4. Spinal Cord Stimulation
		9.5. Transcutaneous Electrical Neuromuscular Stimulation (TENS)
		9.6. Spinal Epidural Injection
	10. Demand Analysis 2018 to 2022 and Forecast 2023 to 2033, By Pain Type
		10.1. Cervical Pain
			10.1.1. Arm Pain
		10.2. Thoracolumbar Pain
			10.2.1. Arm Pain
			10.2.2. Leg Pain
		10.3. Lumbar Pain
			10.3.1. Leg Pain
		10.4. Sciatic Pain
			10.4.1. Leg Pain
	11. Demand Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
		11.1. Hospitals
		11.2. Specialty Clinics
		11.3. Ambulatory Surgical Centers
	12. United States Demand Analysis 2018 to 2022 and Forecast 2023 to 2033, by Region
		12.1. Northeast
		12.2. Midwest
		12.3. Southeast
		12.4. Southwest
		12.5. West
	13. Northeast Demand Analysis 2018 to 2022 and Forecast 2023 to 2033
	14. Midwest Demand Analysis 2018 to 2022 and Forecast 2023 to 2033
	15. Southeast Demand Analysis 2018 to 2022 and Forecast 2023 to 2033
	16. Southwest Demand Analysis 2018 to 2022 and Forecast 2023 to 2033
	17. West Demand Analysis 2018 to 2022 and Forecast 2023 to 2033
	18. Structure Analysis
	19. Competition Analysis
		19.1. ZimVie Inc.
		19.2. Medtronic
		19.3. Johnson & Johnson
		19.4. Stryker Corporation
		19.5. Abbott Laboratories
		19.6. Boston Scientific Corporation
		19.7. B Braun (Aesculap, Inc)
		19.8. Becton, Dickinson and Company
		19.9. Globus Medical
		19.10. Alphatec Spine, Inc.
		19.11. Nevro Corp
		19.12. NuVasive, Inc.
		19.13. Orthofix US LLC.
		19.14. Surgalign Spine Technologies, Inc.
		19.15. Precision Spine, Inc.
	20. Assumptions and Acronyms Used
	21. Research Methodology
Recommendations

Healthcare

Back Therapy Kit Market

June 2024

REP-GB-8416

250 pages

Healthcare

Spine Pain Market

May 2024

REP-GB-16283

280 pages

Healthcare

Spinal Cord Stimulators Market

September 2023

REP-GB-2030

324 pages

Healthcare

Joint Replacement Market

December 2022

REP-GB-16281

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Spine Pain Industry Analysis in United States

Schedule a Call